Logo image of HCO-P.CA

HANSCO CAPITAL CORP (HCO-P.CA) Stock Fundamental Analysis

TSX-V:HCO-P - TSX Venture Exchange - CA41130L1004 - Common Stock - Currency: CAD

0.085  +0.05 (+142.86%)

Fundamental Rating

2

Overall HCO-P gets a fundamental rating of 2 out of 10. We evaluated HCO-P against 0 industry peers in the Unkown industry. No worries on liquidiy or solvency for HCO-P as it has an excellent financial health rating, but there are worries on the profitability. HCO-P does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

HCO-P had negative earnings in the past year.
In the past year HCO-P has reported a negative cash flow from operations.
HCO-P.CA Yearly Net Income VS EBIT VS OCF VS FCFHCO-P.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -20K -40K -60K

1.2 Ratios

Industry RankSector Rank
ROA -16.66%
ROE -17.77%
ROIC N/A
ROA(3y)-21.41%
ROA(5y)N/A
ROE(3y)-22.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HCO-P.CA Yearly ROA, ROE, ROICHCO-P.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -5 -10 -15 -20 -25

1.3 Margins

HCO-P does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HCO-P.CA Yearly Profit, Operating, Gross MarginsHCO-P.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, HCO-P has about the same amount of shares outstanding.
HCO-P has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HCO-P.CA Yearly Shares OutstandingHCO-P.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
HCO-P.CA Yearly Total Debt VS Total AssetsHCO-P.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50K 100K 150K 200K 250K

2.2 Solvency

HCO-P has an Altman-Z score of 10.32. This indicates that HCO-P is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for HCO-P. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 10.32
ROIC/WACCN/A
WACCN/A
HCO-P.CA Yearly LT Debt VS Equity VS FCFHCO-P.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 100K 200K

2.3 Liquidity

HCO-P has a Current Ratio of 15.92. This indicates that HCO-P is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 15.92 indicates that HCO-P has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 15.92
Quick Ratio 15.92
HCO-P.CA Yearly Current Assets VS Current LiabilitesHCO-P.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50K 100K 150K 200K 250K

More info and screens

1

3. Growth

3.1 Past

HCO-P shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.27%, which is quite impressive.
EPS 1Y (TTM)49.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.05%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HCO-P.CA Yearly Revenue VS EstimatesHCO-P.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024
HCO-P.CA Yearly EPS VS EstimatesHCO-P.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
HCO-P.CA Price Earnings VS Forward Price EarningsHCO-P.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HCO-P.CA Per share dataHCO-P.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HCO-P!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HANSCO CAPITAL CORP

TSX-V:HCO-P (3/3/2025, 7:00:00 PM)

0.085

+0.05 (+142.86%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)05-28 2025-05-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners47.62%
Ins Owner ChangeN/A
Market Cap535.50K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.1
P/tB 3.1
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.66%
ROE -17.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-21.41%
ROA(5y)N/A
ROE(3y)-22.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.92
Quick Ratio 15.92
Altman-Z 10.32
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.05%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.78%
OCF growth 3YN/A
OCF growth 5YN/A